Home
AMGN
AMGN News

Latest Amgen Inc. (AMGN) News on May 9, 2025

2 Unstoppable Dividend Stocks to Buy and Hold Forever

Motley Fool

a day ago

2 Unstoppable Dividend Stocks to Buy and Hold Forever

Amgen Inc. (AMGN): A Bull Case Theory

Insider Monkey

2 days ago

Amgen Inc. (AMGN): A Bull Case Theory

Is Amgen Inc. (AMGN) the Best Dow Stock?

Insider Monkey

2 days ago

Is Amgen Inc. (AMGN) the Best Dow Stock?

Here's Why Amgen (AMGN) is a Strong Growth Stock

Zacks

2 days ago

Here's Why Amgen (AMGN) is a Strong Growth Stock

Morningstar Research

3 days ago

Analyst Report: Amgen Inc.

MT Newswires

3 days ago

Mizuho Raises Price Target on Amgen to $280 From $235

Here's Why Amgen (AMGN) is a Strong Value Stock

Zacks

3 days ago

Here's Why Amgen (AMGN) is a Strong Value Stock

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

Zacks

4 days ago

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

AMGN's Key Drugs Repatha, Evenity & Blincyto Drive Q1 Sales Growth

Zacks

4 days ago

AMGN's Key Drugs Repatha, Evenity & Blincyto Drive Q1 Sales Growth

Amgen (NasdaqGS:AMGN) Reports Strong Q1 Earnings With Revenue Increase To US$8 Billion

Simply Wall St.

7 days ago

Amgen (NasdaqGS:AMGN) Reports Strong Q1 Earnings With Revenue Increase To US$8 Billion

MT Newswires

7 days ago

Citigroup Adjusts Price Target on Amgen to $300 From $290

Morningstar Research

7 days ago

Analyst Report: Amgen Inc.

Amgen’s Stelara biosimilar gets off to fast start

BioPharma Dive

7 days ago

Amgen’s Stelara biosimilar gets off to fast start

Thomson Reuters StreetEvents

7 days ago

Q1 2025 Amgen Inc Earnings Call

MT Newswires

7 days ago

UBS Adjusts Price Target on Amgen to $315 From $319, Maintains Neutral Rating

Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth

Zacks

7 days ago

Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth

MT Newswires

7 days ago

RBC Trims Price Target on Amgen to $320 From $324, Keeps Outperform Rating

Amgen Inc (AMGN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Pricing Challenges

GuruFocus.com

8 days ago

Amgen Inc (AMGN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Pricing Challenges

Compared to Estimates, Amgen (AMGN) Q1 Earnings: A Look at Key Metrics

Zacks

8 days ago

Compared to Estimates, Amgen (AMGN) Q1 Earnings: A Look at Key Metrics

Amgen (AMGN) Tops Q1 Earnings and Revenue Estimates

Zacks

8 days ago

Amgen (AMGN) Tops Q1 Earnings and Revenue Estimates

Investing.com

8 days ago

Amgen beats Q1 expectations, issues solid full-year outlook

Beat the Nasdaq With This Cash-Gushing Dividend Stock

Motley Fool

8 days ago

Beat the Nasdaq With This Cash-Gushing Dividend Stock

Amazon and Apple earnings coverage, Eli Lilly: What to Watch

Yahoo Finance Video

9 days ago

Amazon and Apple earnings coverage, Eli Lilly: What to Watch

Is Amgen Inc. (AMGN) the Best Dow Stock for the Next 12 Months?

Insider Monkey

9 days ago

Is Amgen Inc. (AMGN) the Best Dow Stock for the Next 12 Months?

Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?

Zacks

9 days ago

Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?

Amgen (AMGN) Reports Earnings Tomorrow: What To Expect

StockStory

10 days ago

Amgen (AMGN) Reports Earnings Tomorrow: What To Expect

Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know

Zacks

10 days ago

Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know

Can Amgen Keep the Beat Streak Alive This Earnings Season?

Zacks

10 days ago

Can Amgen Keep the Beat Streak Alive This Earnings Season?

The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron

Zacks

10 days ago

The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron

AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS

PR Newswire

11 days ago

AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS

Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?

Zacks

11 days ago

Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?

Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs

GuruFocus.com

11 days ago

Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs

MT Newswires

11 days ago

HSBC Adjusts Amgen Price Target to $357 From $385, Maintains Buy Rating

Amgen (AMGN) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks

11 days ago

Amgen (AMGN) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Amgen to invest $900m in Ohio manufacturing facility

Pharmaceutical Technology

11 days ago

Amgen to invest $900m in Ohio manufacturing facility

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

Motley Fool

13 days ago

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment

Simply Wall St.

13 days ago

Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment

Pharma reshoring: Amgen invests $900M in Ohio biotech facility

Yahoo Finance Video

14 days ago

Pharma reshoring: Amgen invests $900M in Ohio biotech facility

MT Newswires

14 days ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires

14 days ago

Amgen Reports $900 Million Manufacturing Expansion in Ohio

Amgen to expand Ohio biotech manufacturing plant

Reuters

14 days ago

Amgen to expand Ohio biotech manufacturing plant

AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO

PR Newswire

14 days ago

AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO

Amgen (AMGN) Earnings Expected to Grow: Should You Buy?

Zacks

15 days ago

Amgen (AMGN) Earnings Expected to Grow: Should You Buy?

1 Value Stock to Research Further and 2 to Ignore

StockStory

15 days ago

1 Value Stock to Research Further and 2 to Ignore

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

Motley Fool

17 days ago

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

Is Amgen Inc. (AMGN) a Cheap NASDAQ Stock to Buy According to Hedge Funds?

Insider Monkey

17 days ago

Is Amgen Inc. (AMGN) a Cheap NASDAQ Stock to Buy According to Hedge Funds?

Investing.com

17 days ago

Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy

Amgen (AMGN) Stock Moves -1.3%: What You Should Know

Zacks

18 days ago

Amgen (AMGN) Stock Moves -1.3%: What You Should Know

Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now?

Zacks

18 days ago

Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now?

Here's Why Amgen (AMGN) is a Strong Value Stock

Zacks

21 days ago

Here's Why Amgen (AMGN) is a Strong Value Stock

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Zacks

22 days ago

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Amgen Inc. (AMGN): Among the Innovative Healthcare Stocks to Watch in 2025

Insider Monkey

22 days ago

Amgen Inc. (AMGN): Among the Innovative Healthcare Stocks to Watch in 2025

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

Motley Fool

22 days ago

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

Leqembi finally secures EU clearance; Sandoz sues Amgen over Enbrel patents

BioPharma Dive

24 days ago

Leqembi finally secures EU clearance; Sandoz sues Amgen over Enbrel patents

MT Newswires

24 days ago

Goldman Sachs Adjusts Price Target on Amgen to $400 From $408, Maintains Buy Rating

MT Newswires

25 days ago

Sector Update: Health Care Stocks Rise Monday Afternoon

MT Newswires

25 days ago

Update: Amgen Facing US Antitrust Lawsuit Filed by Sandoz

MT Newswires

25 days ago

UBS Adjusts Amgen Price Target to $319 From $315, Maintains Neutral Rating

MT Newswires

25 days ago

Goldman Sachs Adjusts Price Target on Amgen to $400 From $408

Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit

Pharmaceutical Technology

25 days ago

Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit

MT Newswires

a month ago

Amgen Facing US Antitrust Lawsuit Filed by Sandoz

Amgen’s Phase III trial of Imdelltra meets primary endpoint for SCLC

Clinical Trials Arena

a month ago

Amgen’s Phase III trial of Imdelltra meets primary endpoint for SCLC

Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug

Reuters

a month ago

Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug

Amgen (AMGN) Gains But Lags Market: What You Should Know

Zacks

a month ago

Amgen (AMGN) Gains But Lags Market: What You Should Know

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires

a month ago

Sector Update: Health Care Stocks Gain in Afternoon Trading

Amgen (NasdaqGS:AMGN) Clinical Trial Success In SCLC Treatment With IMDELLTRA

Simply Wall St.

a month ago

Amgen (NasdaqGS:AMGN) Clinical Trial Success In SCLC Treatment With IMDELLTRA

MT Newswires

a month ago

Citigroup Adjusts Price Target on Amgen to $290 From $295, Keeps Neutral Rating

MT Newswires

a month ago

Amgen Says Phase 3 Trial of Lung Cancer Drug Imdelltra Met Primary Endpoint at Interim

IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER

PR Newswire

a month ago

IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER

Amgen says Imdelltra extended survival; Parker Institute adds new leaders

BioPharma Dive

a month ago

Amgen says Imdelltra extended survival; Parker Institute adds new leaders

Pharma’s manufacturing moment: Where companies are making the biggest moves

Pharma Voice

a month ago

Pharma’s manufacturing moment: Where companies are making the biggest moves

The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Zacks

a month ago

The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Amgen Is Getting Into the Obesity Drug Business. Buy the Stock Before It Becomes the Next Winner.

Barrons.com

a month ago

Amgen Is Getting Into the Obesity Drug Business. Buy the Stock Before It Becomes the Next Winner.

MT Newswires

a month ago

Morgan Stanley Adjusts Price Target on Amgen to $330 From $328, Keeps Equalweight Rating

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.

Barrons.com

a month ago

This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.

3 Dividend Stocks to Buy and Hold for the Next Decade

Motley Fool

a month ago

3 Dividend Stocks to Buy and Hold for the Next Decade

2 Dividend Stocks to Buy Hand Over Fist in April

Motley Fool

a month ago

2 Dividend Stocks to Buy Hand Over Fist in April

Amgen (NasdaqGS:AMGN) Gains FDA Approval For UPLIZNA In Treating IgG4-Related Disease

Simply Wall St.

a month ago

Amgen (NasdaqGS:AMGN) Gains FDA Approval For UPLIZNA In Treating IgG4-Related Disease

AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication

Zacks

a month ago

AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication

MT Newswires

a month ago

Sector Update: Health Care Stocks Decline Pre-Bell Friday

MT Newswires

a month ago

Amgen Says Uplizna Wins US FDA Approval for IgG4-related Disease

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Zacks

a month ago

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

Motley Fool

a month ago

Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE

PR Newswire

a month ago

UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE

US FDA approves Amgen's Uplizna as first treatment for rare immune disorder

Reuters

a month ago

US FDA approves Amgen's Uplizna as first treatment for rare immune disorder

MT Newswires

a month ago

RBC Lifts Price Target on Amgen to $324 From $320, Keeps Outperform Rating

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

StockStory

a month ago

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now

Motley Fool

a month ago

Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now

GILD or AMGN: Which Is the Better Value Stock Right Now?

Zacks

a month ago

GILD or AMGN: Which Is the Better Value Stock Right Now?

Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1

Investor's Business Daily

a month ago

Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1

These biotech names aren't facing 'huge concern' from tariffs

Yahoo Finance Video

a month ago

These biotech names aren't facing 'huge concern' from tariffs

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

a month ago

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

Zacks

a month ago

RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

2 Surefire Dividend Stocks That Could Pay You for Life

Motley Fool

a month ago

2 Surefire Dividend Stocks That Could Pay You for Life

2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down

StockStory

a month ago

2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Motley Fool

a month ago

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

Barrons.com

a month ago

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

Share on Social Networks: